Aerovate Therapeutics, Inc.
Aerovate Therapeutics, Inc. (AVTE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AVTE · as of Jun 9, 2026
Key Statistics
Explore Aerovate Therapeutics, Inc. Data
avte stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 25.0%
The AVTE analyst consensus is Hold, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $13.00, representing +385.07% upside from the current price of $2.68.
Competitors & Peers
avte competitorsAVTE
ACHL
BLI
IGMS
IMDX
LABPStock Performance
Full HistoryAbout Aerovate Therapeutics, Inc.
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across …
what is aerovate therapeutics, inc. · avte stock overview · aerovate therapeutics, inc. company profile · who is aerovate therapeutics, inc. ceo · avte NASDAQ · aerovate therapeutics, inc. headquarters · aerovate therapeutics, inc. business segments
About Stock Overview & Key Data
Aerovate Therapeutics, Inc. (AVTE) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 30, 2021. As of the latest trading session, AVTE stock price is $2.68, with a market capitalization of $77.7M. The stock has returned -99.52% over the past 12 months and -97.15% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Aerovate Therapeutics, Inc. stock is Hold, with an average 12-month price target of $13.00. In fiscal year 2025, Aerovate Therapeutics, Inc. reported revenue of — and net income of -$127.4M. For detailed data — including Aerovate Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Aerovate Therapeutics, Inc. (AVTE) stock price is $2.68. The stock is traded on NASDAQ under the ticker symbol AVTE. The 52-week range is $2.63 – $884.98.